Peek Behind the Paper: Availability of comparative RWE in Medicare patients – implications for CMS drug price negotiations

In this interview we speak with authors Ashley Jaksa, Market Access Scientific Strategy Lead and Pat Arena, Director, Epidemiology at Aetion (NY, USA) about their recent scoping review entitled "Availability of comparative real-world evidence research in Medicare patients: implications for Centers for Medicare and Medicaid Services drug price negotiations" published in the Journal of Comparative Effectiveness Research. Please could you introduce yourselves and give a brief overview of your careers to date? Ashley Jaksa: First, thank you for your interest in our paper and for taking the time to speak with us. I’m Ashley Jaksa, and I started out in...